Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jurnal Kesehatan Andalas
Reno Bestari
Departemen Neurologi, Fakultas Kedokteran, Universitas Andalas
Health Professions

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Terapi plasmaferesis pada penderita Sindrom Guillain-Barré: Sebuah tinjauan sistematis (Plasmapheresis therapy in patients with Guillain-Barré syndrome: A systematic review) Raisa Ainul Mardiyah; Restu Susanti; Rudy Afriant; Zelly Dia Rofinda; Reno Bestari; Almurdi
Jurnal Kesehatan Andalas Vol. 15 No. 2 (2026): July 2026
Publisher : Faculty of Medicine, Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jka.v15i2.2765

Abstract

Plasmapheresis therapy is one of the treatment modalities for Guillain-Barré syndrome (GBS). However, this therapy poses significant challenges, particularly in Indonesia, due to its high cost and complex procedures. Objective: To describe the epidemiological characteristics of GBS patients, assess the indications, effectiveness, safety, and therapeutic responses of plasmapheresis among its variants. Methods: This systematic review was conducted by searching several databases for articles published between January 2020 and May 2025. Based on the established eligibility criteria, 10 articles were included for this review. Results: The majority of GBS patients were male, with a wide age range from 2 to 70 years old, and various GBS types. Most studies have indicated that plasmapheresis therapy significantly improved clinical outcomes in GBS patients, and that it was more effective when administered within 7–10 days of symptom onset. Plasmapheresis was also reported as a relatively safe therapy with tolerable side effects. However, GBS variants and the patient’s initial condition may influence the response to plasmapheresis therapy. Conclusion: Plasmapheresis therapy has been proven to provide meaningful clinical benefits for most GBS patients. Keywords:  efficacy, functional outcomes, Guillain-Barré syndrome, plasmapheresis, safety
Co-Authors Almurdi Raisa Ainul Mardiyah Restu Susanti Rudy Afriant Zelly Dia Rofinda